Eefsen, R. L., Kongsted, P., Spindler, N. J., Theile, S., Al-Farra, G. J., Hendel, H. W., Lorentzen, T., Persson, G., Behrens, C., Chen, I. M., Madsen, K., Sengeloev, L., Svane, I. M., Nielsen, D., Lindberg, H. (2025). CA209-8TY trial, a randomized phase 2 trial of nivolumab and ipilimumab with or without stereotactic body radiation therapy in metastatic castration-resistant prostate cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.5018